Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
This study has been completed.
Study NCT00136487 Information provided by Dana-Farber Cancer Institute
First Received: August 26, 2005 Last Updated: December 20, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Celecoxib
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Dana-Farber Cancer Institute
Pfizer
Beth Israel Deaconess Medical Center
Emerson Hospital
Faulkner Hospital
Hartford Hospital
Lowell General Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
University of Michigan Cancer Center
Back to top of Main Content
